Halozyme Therapeutics Inc
HALO
$62.9+0.80 (+1.29%)
Aug 8, 2025, 4:00 PM
Financials
| 52Week High | 70.51 | 52Week Low | 42.01 |
| Beta | 1.17 | Current Ratio Annual | 7.80 |
| Current Ratio Quarterly | 8.36 | Gross Margin TTM | 84.20 |
| Market Cap | 7.36B | Net Profit Margin TTM | 47.28 |
| Operating Margin TTM | 57.92 | Price To Book | 22.11 |
| Price To Earnings TTM | 13.20 | Price To Free Cash Flow TTM | 13.61 |
| Price To Sales TTM | 6.24 | Quick Ratio Annual | 6.50 |
| Quick Ratio Quarterly | 6.44 | Return On Assets TTM | 26.44 |
| Return On Equity TTM | 136.63 | Return On Investment TTM | 29.11 |
| Revenue Growth3Y | 31.82 | Revenue Growth5Y | 38.95 |
| Revenue Growth Quarterly Yoy | 40.79 | Revenue Growth TTMYoy | 34.97 |
| Revenue Per Share TTM | 9.49 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 534 | 88 | 54 | 213 | 160 | 66 | 120.90M | $7.30B |
| Jun 30, 2025 | 241 | 29 | 47 | 71 | 95 | 37 | 16.94M | $840.84M |
| Change | 293(55%) | 59(67%) | 7(13%) | 142(67%) | 65(41%) | 29(44%) | 103.96M(86%) | $6.46B(88%) |